Real World Registry for Use of the Ion Endoluminal System
Recruiting at 16 trial locations
HG
LS
LS
Overseen ByLindsay Seibel, BSc, CCRP
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Intuitive Surgical
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Trial Summary
What is the purpose of this trial?
The primary objective of this study is to evaluate the performance of the Ion Endoluminal System with real-world use for pulmonary lesion localization or biopsy.
Research Team
JR
Janani Reisenauer, MD
Principal Investigator
Mayo Clinic
MP
Michael Pritchett, DO, MPH
Principal Investigator
FirstHealth of the Carolinas
Eligibility Criteria
Inclusion Criteria
You must be 18 years of age or older to participate in this study.
You are eligible for a planned lung lesion localization or biopsy procedure using the Ion Endoluminal System.
You comprehend and abide by the study regulations, as well as provide informed consent.
Treatment Details
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Subjects with biopsy, with or without localization, of pulmonary lesion using Ion Endoluminal SystemExperimental Treatment1 Intervention
Subjects in which a pulmonary lesion biopsy, with or without localization, was attempted or performed with the Ion Endoluminal System.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Intuitive Surgical
Lead Sponsor
Trials
80
Recruited
49,600+
Gary Guthart
Intuitive Surgical
Chief Executive Officer since 2010
PhD in Engineering, California Institute of Technology
Henry Charlton
Intuitive Surgical
Chief Medical Officer since 2023
MD from an unspecified institution
Other People Viewed
By Subject
By Trial
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.